698 related articles for article (PubMed ID: 18036082)
1. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
Lemoine P; Nir T; Laudon M; Zisapel N
J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
[TBL] [Abstract][Full Text] [Related]
3. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
Luthringer R; Muzet M; Zisapel N; Staner L
Int Clin Psychopharmacol; 2009 Sep; 24(5):239-49. PubMed ID: 19584739
[TBL] [Abstract][Full Text] [Related]
4. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
[TBL] [Abstract][Full Text] [Related]
5. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs].
Zisapel N
Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367
[TBL] [Abstract][Full Text] [Related]
6. Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients.
Tarrasch R; Laudon M; Zisapel N
Hum Psychopharmacol; 2003 Dec; 18(8):603-10. PubMed ID: 14696019
[TBL] [Abstract][Full Text] [Related]
7. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
[TBL] [Abstract][Full Text] [Related]
8. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects.
Valtonen M; Niskanen L; Kangas AP; Koskinen T
Nord J Psychiatry; 2005; 59(3):217-21. PubMed ID: 16195124
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
10. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
Wade AG; Crawford G; Ford I; McConnachie A; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
Lydiard RB; Lankford DA; Seiden DJ; Landin R; Farber R; Walsh JK
J Clin Sleep Med; 2006 Jul; 2(3):309-15. PubMed ID: 17561543
[TBL] [Abstract][Full Text] [Related]
12. Ramelteon for the treatment of insomnia.
Borja NL; Daniel KL
Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
[TBL] [Abstract][Full Text] [Related]
13. Sleep complaints: Whenever possible, avoid the use of sleeping pills.
Prescrire Int; 2008 Oct; 17(97):206-12. PubMed ID: 19536941
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
Walsh JK; Soubrane C; Roth T
Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
[TBL] [Abstract][Full Text] [Related]
15. Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial.
Peles E; Hetzroni T; Bar-Hamburger R; Adelson M; Schreiber S
Addiction; 2007 Dec; 102(12):1947-53. PubMed ID: 17916225
[TBL] [Abstract][Full Text] [Related]
16. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
[TBL] [Abstract][Full Text] [Related]
17. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
18. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.
Braam W; Didden R; Smits M; Curfs L
J Intellect Disabil Res; 2008 Mar; 52(Pt 3):256-64. PubMed ID: 18261024
[TBL] [Abstract][Full Text] [Related]
19. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
[TBL] [Abstract][Full Text] [Related]
20. A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly.
Cardinali DP; Gvozdenovich E; Kaplan MR; Fainstein I; Shifis HA; Pérez Lloret S; Albornoz L; Negri A
Neuro Endocrinol Lett; 2002 Feb; 23(1):55-60. PubMed ID: 11880863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
